Literature DB >> 30333223

Body Fatness, Adipose Tissue Compartments, and Biomarkers of Inflammation and Angiogenesis in Colorectal Cancer: The ColoCare Study.

Hans-Ulrich Kauczor1, Cornelia M Ulrich2,3, Caroline Himbert4,3, Jennifer Ose4,3, Johanna Nattenmüller1, Christy A Warby4,3, Andreana N Holowatyj4,3, Jürgen Böhm4,3, Tengda Lin4,3, Mariam Haffa5, Biljana Gigic6, Sheetal Hardikar4,3,7, Dominique Scherer8, Lin Zielske5, Petra Schrotz-King5, Torsten Kölsch6, Erin M Siegel9, David Shibata10, Alexis Ulrich6, Martin Schneider6, Stephen D Hursting11.   

Abstract

BACKGROUND: Adiposity has been linked to both risk and prognosis of colorectal cancer; however, the impact of different fat areas [visceral (VFA) vs. subcutaneous fat area (SFA)] is unclear. We investigated associations between adiposity and biomarkers of inflammation and angiogenesis among patients with colorectal cancer.
METHODS: Preoperative serum samples and computed tomography scans were obtained from 188 patients diagnosed with primary invasive stage I-IV colorectal cancer enrolled in the ColoCare Study. Adiposity was assessed by area-based quantification of VFA, SFA, and VFA:SFA ratio on spinal levels L3/L4 and L4/L5. Circulating levels of inflammation (CRP, SAA, sICAM-1, and sVCAM-1) and angiogenesis (VEGF-A and VEGF-D) were assessed from patient sera on the Meso Scale Discovery platform. Partial correlations and regression analyses, adjusted for age, sex, and tumor stage, were performed.
RESULTS: VFA was moderately correlated with CRP and SAA (CRP: L3/L4 and L4/L5:r = 0.21, P = 0.01; SAA: L3/L4:r = 0.17, P = 0.04). The correlation between SFA and the measured biomarkers were weak (r ≤ 0.13, not significant). The ratio of VFA:SFA at L3/L4 was moderately correlated with VEGF-A (r = 0.28, P = 0.0008) and SAA (r = 0.24, P = 0.006), and less so with CRP (r = 0.18, P = 0.04) and sICAM-1 (r = 0.18, P = 0.04). Similar correlations were found for the VFA:SFA ratio at L4/L5.
CONCLUSIONS: We observed an association between visceral adiposity and biomarkers of inflammation and angiogenesis in colorectal cancer. In particular, the VFA:SFA ratio was correlated with circulating levels of the proangiogenic biomarker VEGF-A. IMPACT: Our findings support a direct association of visceral adipose tissue with inflammatory and angiogenic processes, which play fundamental roles in the development and progression of colorectal cancer. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30333223      PMCID: PMC6324954          DOI: 10.1158/1055-9965.EPI-18-0654

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  43 in total

1.  Visceral fat and bevacizumab in metastatic colorectal cancer.

Authors:  A M Jubb
Journal:  Gut       Date:  2010-07-21       Impact factor: 23.059

Review 2.  Energy balance and gastrointestinal cancer: risk, interventions, outcomes and mechanisms.

Authors:  Cornelia M Ulrich; Caroline Himbert; Andreana N Holowatyj; Stephen D Hursting
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-11       Impact factor: 46.802

3.  Dietary Weight Loss and Exercise Effects on Serum Biomarkers of Angiogenesis in Overweight Postmenopausal Women: A Randomized Controlled Trial.

Authors:  Catherine Duggan; Jean de Dieu Tapsoba; Ching-Yun Wang; Anne McTiernan
Journal:  Cancer Res       Date:  2016-07-15       Impact factor: 12.701

4.  Changes in urinary metabolic profiles of colorectal cancer patients enrolled in a prospective cohort study (ColoCare).

Authors:  David B Liesenfeld; Nina Habermann; Reka Toth; Robert W Owen; Eva Frei; Jürgen Staffa; Petra Schrotz-King; Karel D Klika; Cornelia M Ulrich
Journal:  Metabolomics       Date:  2014-12-20       Impact factor: 4.290

5.  CT-based compartmental quantification of adipose tissue versus body metrics in colorectal cancer patients.

Authors:  Johanna Nattenmueller; Hanna Hoegenauer; Juergen Boehm; Dominique Scherer; Michael Paskow; Biljana Gigic; Petra Schrotz-King; Lars Grenacher; Cornelia Ulrich; Hans-Ulrich Kauczor
Journal:  Eur Radiol       Date:  2016-02-06       Impact factor: 5.315

6.  Long-Term Effects of Weight Loss and Exercise on Biomarkers Associated with Angiogenesis.

Authors:  Catherine Duggan; Jean de Dieu Tapsoba; Ching-Yun Wang; Karen E Foster Schubert; Anne McTiernan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-10-17       Impact factor: 4.254

7.  Validating quantitative obesity measurements in colorectal cancer patients.

Authors:  Courtney J Balentine; Christy Marshall; Celia Robinson; Jonathan Wilks; Daniel Anaya; Daniel Albo; David H Berger
Journal:  J Surg Res       Date:  2010-06-13       Impact factor: 2.192

Review 8.  Vascular endothelial growth factor a inhibition in gastric cancer.

Authors:  Do Joong Park; Nicholas J Thomas; Changhwan Yoon; Sam S Yoon
Journal:  Gastric Cancer       Date:  2014-07-04       Impact factor: 7.370

9.  Serum and plasma levels of FGF-2 and VEGF in healthy blood donors.

Authors:  A Larsson; E Sköldenberg; H Ericson
Journal:  Angiogenesis       Date:  2002       Impact factor: 9.596

Review 10.  Mouse models of intestinal inflammation and cancer.

Authors:  Aya M Westbrook; Akos Szakmary; Robert H Schiestl
Journal:  Arch Toxicol       Date:  2016-06-16       Impact factor: 5.153

View more
  12 in total

1.  One-carbon metabolites, B vitamins and associations with systemic inflammation and angiogenesis biomarkers among colorectal cancer patients: results from the ColoCare Study.

Authors:  Cornelia M Ulrich; Mary Playdon; Rama Kiblawi; Andreana N Holowatyj; Biljana Gigic; Stefanie Brezina; Anne J M R Geijsen; Jennifer Ose; Tengda Lin; Sheetal Hardikar; Caroline Himbert; Christy A Warby; Jürgen Böhm; Martijn J L Bours; Fränzel J B van Duijnhoven; Tanja Gumpenberger; Dieuwertje E Kok; Janna L Koole; Eline H van Roekel; Petra Schrotz-King; Arve Ulvik; Andrea Gsur; Nina Habermann; Matty P Weijenberg; Per Magne Ueland; Martin Schneider; Alexis Ulrich
Journal:  Br J Nutr       Date:  2020-02-05       Impact factor: 3.718

2.  The ColoCare Study: A Paradigm of Transdisciplinary Science in Colorectal Cancer Outcomes.

Authors:  Cornelia M Ulrich; Biljana Gigic; Graham A Colditz; Jane C Figueiredo; William M Grady; Christopher I Li; David Shibata; Erin M Siegel; Adetunji T Toriola; Alexis Ulrich; Jürgen Böhm; Jennifer Ose; Richard Viskochil; Martin Schneider
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-12-06       Impact factor: 4.254

3.  Expression Patterns of Xenobiotic-Metabolizing Enzymes in Tumor and Adjacent Normal Mucosa Tissues among Patients with Colorectal Cancer: The ColoCare Study.

Authors:  Jolantha Beyerle; Andreana N Holowatyj; Mariam Haffa; Eva Frei; Biljana Gigic; Petra Schrotz-King; Juergen Boehm; Nina Habermann; Marie Stiborova; Dominique Scherer; Torsten Kölsch; Stephanie Skender; Nikolaus Becker; Esther Herpel; Martin Schneider; Alexis Ulrich; Peter Schirmacher; Jenny Chang-Claude; Hermann Brenner; Michael Hoffmeister; Ulrike Haug; Robert W Owen; Cornelia M Ulrich
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-11-18       Impact factor: 4.254

4.  Pro-inflammatory cytokine polymorphisms in ONECUT2 and HNF4A and primary colorectal carcinoma: a post genome-wide gene-lifestyle interaction study.

Authors:  Su Yon Jung; Jeanette C Papp; Eric M Sobel; Matteo Pellegrini; Herbert Yu; Zuo-Feng Zhang
Journal:  Am J Cancer Res       Date:  2020-09-01       Impact factor: 6.166

5.  Multi-omics Analysis Reveals Adipose-tumor Crosstalk in Patients with Colorectal Cancer.

Authors:  Andreana N Holowatyj; Mariam Haffa; Tengda Lin; Dominique Scherer; Biljana Gigic; Jennifer Ose; Christy A Warby; Caroline Himbert; Clare Abbenhardt-Martin; David Achaintre; Juergen Boehm; Kenneth M Boucher; Audrey Gicquiau; Andrea Gsur; Nina Habermann; Esther Herpel; Hans-Ulrich Kauczor; Pekka Keski-Rahkonen; Matthias Kloor; Magnus von Knebel-Doeberitz; Dieuwertje E Kok; Johanna Nattenmüller; Peter Schirmacher; Martin Schneider; Petra Schrotz-King; Thomas Simon; Per M Ueland; Richard Viskochil; Matty P Weijenberg; Augustin Scalbert; Alexis Ulrich; Laura W Bowers; Stephen D Hursting; Cornelia M Ulrich
Journal:  Cancer Prev Res (Phila)       Date:  2020-07-12

6.  Transcriptome Profiling of Adipose Tissue Reveals Depot-Specific Metabolic Alterations Among Patients with Colorectal Cancer.

Authors:  Mariam Haffa; Andreana N Holowatyj; Mario Kratz; Reka Toth; Axel Benner; Biljana Gigic; Nina Habermann; Petra Schrotz-King; Jürgen Böhm; Hermann Brenner; Martin Schneider; Alexis Ulrich; Esther Herpel; Peter Schirmacher; Beate K Straub; Johanna Nattenmüller; Hans-Ulrich Kauczor; Tengda Lin; Claudia R Ball; Cornelia M Ulrich; Hanno Glimm; Dominique Scherer
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

7.  Genetically determined elevated C-reactive protein associated with primary colorectal cancer risk: Mendelian randomization with lifestyle interactions.

Authors:  Su Yon Jung; Herbert Yu; Matteo Pellegrini; Jeanette C Papp; Eric M Sobel; Zuo-Feng Zhang
Journal:  Am J Cancer Res       Date:  2021-04-15       Impact factor: 6.166

8.  Fusobacterium nucleatum and Clinicopathologic Features of Colorectal Cancer: Results From the ColoCare Study.

Authors:  Yannick Eisele; Patrick M Mallea; Biljana Gigic; W Zac Stephens; Christy A Warby; Kate Buhrke; Tengda Lin; Juergen Boehm; Petra Schrotz-King; Sheetal Hardikar; Lyen C Huang; T Bartley Pickron; Courtney L Scaife; Richard Viskochil; Torsten Koelsch; Anita R Peoples; Maria A Pletneva; Mary Bronner; Martin Schneider; Alexis B Ulrich; Eric A Swanson; Adetunji T Toriola; David Shibata; Christopher I Li; Erin M Siegel; Jane Figueiredo; Klaus-Peter Janssen; Hans Hauner; June Round; Cornelia M Ulrich; Andreana N Holowatyj; Jennifer Ose
Journal:  Clin Colorectal Cancer       Date:  2021-02-27       Impact factor: 4.035

Review 9.  Modeling of the immune response in the pathogenesis of solid tumors and its prognostic significance.

Authors:  Łukasz Zadka; Damian J Grybowski; Piotr Dzięgiel
Journal:  Cell Oncol (Dordr)       Date:  2020-06-02       Impact factor: 6.730

10.  Multiplatform Urinary Metabolomics Profiling to Discriminate Cachectic from Non-Cachectic Colorectal Cancer Patients: Pilot Results from the ColoCare Study.

Authors:  Jennifer Ose; Biljana Gigic; Tengda Lin; David B Liesenfeld; Jürgen Böhm; Johanna Nattenmüller; Dominique Scherer; Lin Zielske; Petra Schrotz-King; Nina Habermann; Heather M Ochs-Balcom; Anita R Peoples; Sheetal Hardikar; Christopher I Li; David Shibata; Jane Figueiredo; Adetunji T Toriola; Erin M Siegel; Stephanie Schmit; Martin Schneider; Alexis Ulrich; Hans-Ulrich Kauczor; Cornelia M Ulrich
Journal:  Metabolites       Date:  2019-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.